News & Events about Revolution Medicines Inc.
Market News Video
23days ago
In trading on Thursday, shares of Revolution Medicines Inc (RVMD) touched a new 52-week high of 28.06/share. Thats a 99.29% rise, or 13.98 per share from the 52-week low of 14.08 set back on 05/12/2022...
Findings Published in the Journal of Medicinal Chemistry Demonstrate Compounds Exceptional Selectivity for mTORC1 over mTORC2 Tumor Regressions Observed During Combination Treatment with a Bi-Steric mTORC1-Selective Inhibitor and a KRASG12C-Selective Inhibitor in Preclinical Lung Cancer Model that ...
Latest Ratings for RVMD
DateFirmActionFromTo Mar 2022StifelUpgradesHoldBuy Nov 2021HC Wainwright & Co.MaintainsBuy Sep 2021StifelInitiates Coverage OnHold
View More Analyst Ratings for RVMD
View the Latest Analyst Ratings
read more...
Market News Video
5 months ago
In trading on Thursday, shares of Revolution Medicines Inc (RVMD) crossed below their 200 day moving average of 22.46, changing hands as low as 22.34 per share. Revolution Medicines Inc shares are currently trading down about 2.1% on the day...
Globe Newswire
6 months ago
REDWOOD CITY, Calif., July 19, 2022 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for RAS-addicted cancers, today announced the pricing of its underwritten public offering of 11,500,000 shares of common stock at a ...